Clinical Trials in Boston

Showing 6181-6200 of 13,548 trials

Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing

NCT02604511

This research study is studying a drug called ibrutinib as a possible treatment for untreated Waldenstrom's Macroglobulinemia (WM).

Waldenstrom's Macroglobulinemia

Dana-Farber Cancer Institute31 participantsStarted Jan 2016

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDPhase 1/2< 1 mile

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

NCT00062816

The purposes of this Phase 1/2 study are to examine the safety, tolerability, and antiviral activity of ISIS 14803, when given in combination with peginterferon alfa and ribavirin, to patients who either failed to have at least a 100-fold HCV reduction at Week 12 of standard therapy or still have detectable HCV at Week 24.

Hepatitis C, Chronic

Ionis Pharmaceuticals, Inc.22 participantsStarted Jun 2003

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Orange, California, United States +22 more locations

Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Find Trials by Condition in Boston

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

The International Diabetes Closed Loop (iDCL) Trial: Protocol 4

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Computer-based Training of Face Recollection to Improve Face Recognition in Developmental Prosopagnosia

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Gene Therapy for Achromatopsia (CNGA3)